Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 3.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.66 | 1.82 |
NAV | ₹110.99 | ₹140.51 |
Fund Started | 22 Aug 2005 | 30 Aug 2005 |
Fund Size | ₹22206.10 Cr | ₹7706.33 Cr |
Exit Load | Exit load of 0.10% if redeemed within 30 days. | Exit load of 1%, if redeemed within 90 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 21.58% | 27.25% |
3 Year | 13.26% | 14.89% |
5 Year | 17.40% | 17.99% |
1 Year
3 Year
5 Year
Equity | 95.07% | 92.62% |
Cash | 4.93% | 7.38% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Reliance Industries Ltd. | 4.55% |
ICICI Bank Ltd. | 4.19% |
HDFC Bank Ltd. | 4.10% |
Kotak Mahindra Bank Ltd. | 4.05% |
Infosys Ltd. | 3.12% |
Larsen & Toubro Ltd. | 3.05% |
Mahindra & Mahindra Ltd. | 2.90% |
Cognizant Technology Solutions Corp. | 2.76% |
Bharti Airtel Ltd. | 2.75% |
Nuvoco Vistas Corporation Ltd. | 2.01% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.63% |
Infosys Ltd. | 6.78% |
Bharti Airtel Ltd. | 5.45% |
Reliance Industries Ltd. | 4.97% |
HDFC Bank Ltd. | 4.88% |
Larsen & Toubro Ltd. | 4.56% |
NTPC Ltd. | 4.10% |
Mahindra & Mahindra Ltd. | 4.07% |
Axis Bank Ltd. | 3.68% |
Sun Pharmaceutical Industries Ltd. | 3.41% |
Name | Rama Iyer Srinivasan | Dhaval Joshi |
Start Date | 08 Sep 2020 | 21 Nov 2022 |
Name
Start Date
Description | The scheme would invest in equities and equity related instruments of companies spanning the entire market capitalization spectrum. The fund will invest 50-90 per cent in large-cap stocks, 10-40 per cent in mid-cap stocks and upto 10 per cent in small-cap stocks. | The Scheme seeks to achieve long term capital appreciation by investing in upto 30 companies with long term sustainable competitive advantage and growth potential |
Launch Date | 22 Aug 2005 | 30 Aug 2005 |
Description
Launch Date